Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), spécialiste international du diagnostic clinique, annonce que la Haute Cour a notifié à Novacyt que l'audience de l'affaire entre...
Le chiffre d'affaires et l'EBITDA sont conformes aux prévisions. Concentration sur la stratégie de croissance post-COVID-19 pour devenir un leader mondial du diagnostic clinique dans le domaine...
Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that Edwin Snape has informed the Board that he wishes to retire...
Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Company’s genesig® COVID-19 3G Real-Time PCR test has been...
Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that David Allmond is stepping down as Chief Executive Officer (CEO...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.027 | -4.4262295082 | 0.61 | 0.644 | 0.571 | 257315 | 0.60281145 | DE |
4 | -0.098 | -14.3906020558 | 0.681 | 0.719 | 0.571 | 332496 | 0.65054517 | DE |
12 | -0.455 | -43.8342967245 | 1.038 | 1.194 | 0.571 | 474142 | 0.81952838 | DE |
26 | -0.128 | -18.0028129395 | 0.711 | 1.59 | 0.497 | 776141 | 0.96069086 | DE |
52 | -0.017 | -2.83333333333 | 0.6 | 1.59 | 0.4932 | 511687 | 0.90280595 | DE |
156 | -3.057 | -83.9835164835 | 3.64 | 5.89 | 0.42 | 563218 | 1.77942024 | DE |
260 | 0.463 | 385.833333333 | 0.12 | 13.62 | 0.1102 | 1788790 | 2.98171938 | DE |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約